PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
33488754-14	2020	Conclusion: Taken together, our results revealed that YSQHP likely exerts its antitumor effects by binding to CASP8, GSK3B, PRKCA, and VEGFR2 and by regulating the apoptosis, p53, and PI3K/AKT pathways.	ysqhp	54-59	caspase 8	Homo sapiens	110-115
33488754-14	2020	Conclusion: Taken together, our results revealed that YSQHP likely exerts its antitumor effects by binding to CASP8, GSK3B, PRKCA, and VEGFR2 and by regulating the apoptosis, p53, and PI3K/AKT pathways.	ysqhp	54-59	glycogen synthase kinase 3 beta	Homo sapiens	117-122
33488754-14	2020	Conclusion: Taken together, our results revealed that YSQHP likely exerts its antitumor effects by binding to CASP8, GSK3B, PRKCA, and VEGFR2 and by regulating the apoptosis, p53, and PI3K/AKT pathways.	ysqhp	54-59	protein kinase C alpha	Homo sapiens	124-129
33488754-14	2020	Conclusion: Taken together, our results revealed that YSQHP likely exerts its antitumor effects by binding to CASP8, GSK3B, PRKCA, and VEGFR2 and by regulating the apoptosis, p53, and PI3K/AKT pathways.	ysqhp	54-59	kinase insert domain receptor	Homo sapiens	135-141
33488754-14	2020	Conclusion: Taken together, our results revealed that YSQHP likely exerts its antitumor effects by binding to CASP8, GSK3B, PRKCA, and VEGFR2 and by regulating the apoptosis, p53, and PI3K/AKT pathways.	ysqhp	54-59	tumor protein p53	Homo sapiens	175-178
33488754-14	2020	Conclusion: Taken together, our results revealed that YSQHP likely exerts its antitumor effects by binding to CASP8, GSK3B, PRKCA, and VEGFR2 and by regulating the apoptosis, p53, and PI3K/AKT pathways.	ysqhp	54-59	AKT serine/threonine kinase 1	Homo sapiens	189-192